CARsgen Therapeutics Holdings Limited provided unaudited consolidated earnings guidance for the year ended December 31, 2021. The company experience an increase in net loss and adjusted net loss. Details are described below: net loss of approximately RMB 4,731 million to RMB4,761 million, as compared to approximately RMB1,064 million for the year ended December 31, 2020, representing an increase of approximately 345% to 347%.